eHealth Support Tool to Improve Quality of Life in Head and Neck Cancer Survivors

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07426874

Enrollment

Registered

2026-02-23

Start date

2025-09-01

Completion date

2026-12-31

Last updated

2026-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head and Neck Cancer (H&N)

Keywords

Head and Neck Cancer

Brief summary

This study evaluates the development, implementation and effectiveness of a nurse-led eHealth support tool designed to improve quality of life and survivorship outcomes among adults treated for head and neck cancer. The intervention integrates symptom monitoring, self-management education, and structured survivorship support into routine follow-up care. Outcomes will include patient-reported quality of life, symptom burden, and healthcare utilization.

Detailed description

Head and neck cancer (HNC) survivors experience significant long-term physical, functional, and psychosocial sequelae including dysphagia, speech impairment, fatigue, pain, and psychological distress. Traditional follow-up models rely on periodic clinic visits and may not adequately support self-management. This study involves three phases: Development of a co-designed eHealth support platform. Implementation of the intervention within survivorship care pathways. Evaluation of clinical effectiveness using patient-reported outcomes and healthcare utilization metrics. The intervention integrates: Symptom tracking Educational resources Self-management tools Structured nurse-guided follow-up The primary hypothesis is that structured digital survivorship support will improve global quality of life compared to usual follow-up care.

Interventions

OTHEReHealth Survivorship Support Tool

A digital platform including: Symptom monitoring Educational modules Self-management guidance Nurse-supported remote follow-up

OTHERControl

Standard follow up

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Adults ≥18 years Diagnosed with head and neck cancer Completed primary treatment (surgery, radiotherapy, chemotherapy or combination) Within 12 months post-treatment Access to smartphone/tablet/internet Able to provide informed consent

Exclusion criteria

Recurrent or metastatic disease requiring active treatment Significant cognitive impairment Inability to use digital device Non-English speakers (if tool not multilingual)

Design outcomes

Primary

Measure	Time frame	Description
Quality of Life EORTC QLQ-C30 (Global Health Status scale)	Baseline, 3 months, 6 months	Measurement Tool: EORTC QLQ-C30 (Global Health Status scale) Time Frame: Baseline, 3 months, 6 months

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026